NLM logo
77 results
  1. ... compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 27 (6): 851-6, 2009. [ PubMed : 19139439 ] Cooper JS, Guo MD, Herskovic A, et al.: Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective ...
  2. ... Modeling the Cost-effectiveness of Strategies for Treating Esophageal Adenocarcinoma ... of Locally Advanced Esophageal Cancer: A Systematic Review and Decision Analysis. ...
  3. ... 90% of all esophageal tumors. The incidence of esophageal adenocarcinomas has risen considerably for the past two decades, ... human papillomavirus),[ 5 ] the risk factors associated with esophageal adenocarcinoma are less defined. The most important epidemiological difference ...
  4. ... esophagus is associated with an increased risk of esophageal adenocarcinoma. Other factors that may explain the increased risk ... A meta-analysis of 1,128 individuals with esophageal adenocarcinoma from five case-control studies reported statistically significant ...
  5. ... O, et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointestinal Endoscopy. 2007; 65 :3– ... al. Endoscopic and Surgical Treatment of Mucosal (T1a) Esophageal Adenocarcinoma in Barrett's Esophagus. Gastroenterology. 2009; 137 :815– ...
  6. ... known as Barrett’s esophagus, as well as esophageal adenocarcinoma. These GERD complications can result in hospitalizations for ... an esophageal disorder. From 1998 to 2005, dysphagia, esophageal adenocarcinoma, and esophagitis were the fastest growing esophageal disorders ...
  7. ... O, et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett’s cancer). Gastrointestinal Endoscopy. 2007; 65 :3– ... al. Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett’s esophagus. Gastroenterology. 2009; 137 :815– ...
  8. ... of ASA had significantly reduced the risk of esophageal adenocarcinoma (OR, 0.68 [95% CI, 0.56 to ... meta-analysis also found a reduced risk of esophageal adenocarcinoma in 14 observational studies with ASA use (OR, ...
  9. ... called for further research on the risk of esophageal adenocarcinoma. Our updated analysis found that studies vary widely ... 202 , 251 , 254 , 255 and no reports of esophageal adenocarcinoma. Cardiovascular Events The 2010 review noted no clear ...
  10. ... diaphysis in long-term users of alendronate; and esophageal adenocarcinoma. Evidence on harms associated with calcitonin, parathyroid hormone, ... recently issued a report summarizing 54 cases of esophageal adenocarcinoma associated with bisphosphonate (primarily alendronate) use, and called ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · next · last